Product record
Amrox Ls Levosalbutamol Sulphate Amborxol Hydrochloride Guaipenesin: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
1 batch of products named "Amrox Ls Levosalbutamol Sulphate Amborxol Hydrochloride Guaipenesin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between February 2025 and February 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
1 record linked to Amrox Ls Levosalbutamol Sulphate Amborxol Hydrochloride Guaipenesin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| AJLH24 051Mfg 2024-06 · Exp 2026-05 | Leeford Healthcare LtdHimachal Pradesh | MISBRANDED DRUG In the composition the label should be mentioned as Levosalbutamol Sulphate IP equivalent to Levosalbutamol. But the label is mentioned as only Levosalbutamol Sulphate IP, equivalent to Levosalbutamol as not mentioned. Hence it is a Misbranded drug as per section 17 of Drugs and Cosmetics Act, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab | Feb 2025 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.